XML 27 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net loss $ (36,100,000) $ (39,842,000) $ (28,702,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 99,000 146,000 85,000
Gain on bargain purchase     (486,000)
Impairment of IPR&D 6,049,000    
Benefit for deferred tax liability (2,409,000)    
Share-based compensation expense related to employee stock options 2,643,000 2,675,000 2,032,000
Write-off of property and equipment 36,000 6,000 0
Amortization of debt issuance costs and debt discount 1,009,000 185,000  
Changes in assets and liabilities, net of effect of acquisitions:      
Increase/(decrease) in prepaid expenses and other assets 363,000 13,000 (58,000)
(Decrease)/increase in accounts payable (1,974,000) 1,230,000 406,000
(Decrease)/increase in accrued liabilities (6,983,000) 2,638,000 2,078,000
Net cash used in operating activities (37,267,000) (32,949,000) (24,645,000)
Cash flows from investing activities:      
Purchases of certificates of deposit   (13,713,000) (19,435,000)
Proceeds from maturities of certificates of deposit 15,207,000 17,024,000 16,659,000
Proceeds from sales of certificates of deposit   249,000  
Purchases of property and equipment (8,000) (165,000) (147,000)
Security deposit for new lease     (130,000)
Cash obtained through acquisition     3,534,000
Net cash provided by investing activities 15,199,000 3,395,000 481,000
Cash flows from financing activities:      
Proceeds from borrowings under debt facility   15,000,000  
Payments made on debt facility (11,653,000)    
Costs paid in connection with debt facility (123,000) (193,000)  
Proceeds from sale of common stock 19,958,000 2,140,000 30,201,000
Proceeds from sale and exercise of warrants 473,000   6,148,000
Payments for offering costs (1,089,000) (142,000) (2,058,000)
Payments for capital lease (8,000) (7,000)  
Net cash provided by financing activities 7,558,000 16,798,000 34,291,000
Net (decrease)/increase in cash and cash equivalents (14,510,000) (12,756,000) 10,127,000
Cash and cash equivalents at beginning of period 23,052,000 35,808,000 25,681,000
Cash and cash equivalents at end of period $ 8,542,000 $ 23,052,000 $ 35,808,000